Related Experiment Videos
A simulation study to determine optimal insulin priming during glucose clamp studies
R Hovorka1, J K Powrie, R H Jones
1Department of Systems Science, City University, London, UK.
Computer Methods and Programs in Biomedicine
|January 1, 1994
Summary
Optimizing insulin kinetics in hyperinsulinaemic euglycaemic clamp studies (HECS) is crucial. A specific insulin priming regimen ensures accurate glucose uptake measurements in patients with non-insulin-dependent diabetes mellitus.
Area of Science:
- Endocrinology
- Metabolic Research
- Computational Biology
Background:
- Hyperinsulinaemic euglycaemic clamp studies (HECS) are vital for assessing insulin sensitivity.
- Accurate insulin kinetics modeling is essential for reliable HECS results.
- Patients with non-insulin-dependent diabetes mellitus often require optimized HECS protocols.
Purpose of the Study:
- To investigate the impact of different insulin priming strategies on glucose uptake equilibrium during HECS.
- To determine the optimal insulin priming regimen for achieving steady-state glucose uptake within 90 minutes.
- To evaluate the accuracy of conventional priming methods in HECS.
Main Methods:
- Computer simulation using a novel model of insulin kinetics.
- Analysis of glucose uptake and plasma insulin concentration under various priming conditions.
- Comparison of a 10-min, six-fold higher rate insulin infusion priming with bolus and monoexponential-decay priming.
Main Results:
- A 10-min insulin infusion priming at six times the target rate achieves glucose uptake equilibrium within 90 minutes.
- Alternative priming regimens (bolus, monoexponential-decay) also reach equilibrium but cause higher insulin transients.
- No priming or conventional priming results in only ~80% of equilibrium glucose uptake at 90 minutes.
Conclusions:
- Insulin priming is essential for achieving steady-state glucose uptake within 90 minutes in HECS.
- Conventional priming regimens may lead to an underestimation of glucose uptake.
- The simulated 10-min, high-rate insulin infusion priming offers an effective strategy for HECS in non-insulin-dependent diabetes mellitus.